Three health-technology names are drawing fresh analyst attention this week as strategic partnerships and business pivots reframe the risk-reward calculus for each. Hims & Hers Health (NYSE:HIMS) received two separate upgrades after…
Pre-Market Stock Futures: Futures are trading lower as many across Wall Street breathed a semi-sigh of relief yesterday after oil futures, which shot up to $120 overnight, retreated below $100 on Monday.…
Live Updates Oil Price Forecast 12:39pm ETIf Americans think prices at the pump are high now, they may be in for a shock. Energy research firm Rystad Energy predicts that oil could…
In a dramatic reversal of fortune, Hims & Hers Health (NYSE:HIMS) has been rescued by the very company that nearly sank it. Novo Nordisk (NYSE:NVO | NVO Price Prediction), which sued the…
Rich Duprey Shares of Hims & Hers Health (NYSE:HIMS) are trading lower this morning after yesterday’s earnings, and the reason is straightforward: guidance. Yesterday we were watching whether management could offer a credible forward…
Hims & Hers Health (NYSE: HIMS) delivered a beat on both earnings and profitability in Q4 2025, though a soft 2026 revenue guidance is keeping the stock under pressure after a sharp…
Trey Thoelcke Hims & Hers Health (NYSE:HIMS) just made a bold move to take its personalized wellness platform global. The company announced it is acquiring Eucalyptus, a leading digital health player based in Australia,…
Rich Duprey Hims & Hers Health (NYSE:HIMS) has crashed 47.96% over the past month, falling from $31.32 on January 14 to $16.30 as of February 13. Yet Wall Street analysts still see the telehealth…
Joel South One of the biggest trends in the fight against obesity has been the explosion in popularity of GLP-1 medications. Created to treat diabetes, patients who were prescribed the popular GLP-1 drugs Ozempic,…
Shares of Hims & Hers Health (NYSE:HIMS) plunged 22% at market open on Monday, February 9. The telehealth company pulled its copycat semaglutide weight-loss pill over the weekend after threats of legal…
Hims & Hers Health (NASDAQ: HIMS) has had among the worst runs of any public company over the last year. And, there is little reason to think it will recover. The stock…
Hims & Hers (NYSE:HIMS) shares are plunging 16% in after-hours trading following coordinated moves by two federal agencies against its compounded weight-loss drugs. The Food and Drug Administration (FDA) announced plans to…
Rich Duprey Pre-Market Stock Futures: The futures are trading lower on Monday morning after a strong finish to the week on Friday, completing a winning week for investors as all three of the major…
Hims & Hers Health (NYSE: HIMS) went public in January 2021 through a SPAC merger, positioning itself as a multi-specialty telehealth platform offering prescription medications, mental health support, and personal care products.…
William Temple Live Updates What We Learned From the Quarterly Conference call 6:04pm ETThe call centered around Hims & Hers’ push beyond treatment into proactive and personalized health management. Dudum confirmed plans to launch…
Joel South 
